Menu Skip to Content

Gennady Bratslavsky, MD, 315 464-4473

Gennady Bratslavsky, MD
Appointed 04/04/11
Women's Health Network
233 Campus West Building (CWB)
750 East Adams Street
Syracuse, NY 13210

315 464-4473

Current Appointments

Hospital Campus

  • Downtown
  • Community

Clinical Section Affiliations

  • Upstate Cancer Center: Urologic Surgery/Oncology
  • Urology: Adult Urology, Female Urologic Oncology (Kidney and Bladder), Female Urology & Urodynamics, General Female Urologic Health, Minimally Invasive Surgery, Robotic & Laparoscopic Surgery, Urologic Male Health, Urologic Oncology
  • Women's Health Network: Pelvic Health, Urologic Care

Research Programs and Affiliations

  • Biomedical Sciences Program

Featured Video

Clinic/Unit

Education & Fellowships

  • Fellowship: National Cancer Institute, NIH, Bethesda, MD, 2007, Urologic Oncology
  • Residency: Albany Medical Center Hospital, 2005, Urologic Surgery
  • MD: Albany Medical College, NY, 2000

Previous Appointments

  • National Cancer Institute, NIH, Bethesda, MD, 2005–2011
  • Albany Medical Center Hospital, 2000–2005

Clinical Interests

  • Outcome evaluations of minimally invasive robot-assisted and laparoscopic prostate and kidney surgery

Education Interests

  • Resident and student mentoring in basic and clinical research

Research Interests

  • Basic, clinical, and translational prostate, bladder, and kidney research.   

Clinical Trials

  • A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF ATEZOLIZUMAB (ANTI−PD-L1 ANTIBODY) AS ADJUVANT THERAPY IN PATIENTS WITH RENAL CELL CARCINOMA AT HIGH RISK OF DEVELOPING METASTASIS FOLLOWING NEPHRECTOMY
    Read more
  • A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN® (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC).
    Read more
  • A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (ENACT)
    Read more
  • An Open-Label, Multicenter, Phase 3 Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium™ in Subjects with Non Muscle-Invasive Carcinoma in Situ (CIS) and/or High-Grade Papillary Disease of the Bladder Previously Treated with Bacillus Calmette-Guérin (BCG)
    Read more
  • Collection of Urine, Serum, and Tissue Samples from Patients with Biopsy-Proven or Suspected Urologic Malignancies
    Read more
  • EA8141 - A Prospective Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery for Patients with High Grade Upper Tract Urothelial Carcinoma
    Read more
  • Prospective Evaluation of the Incidence of Extraintestinal Pathogenic Escherichia coli (ExPEC) Disease, O-serotype Prevalence of ExPEC, ExPEC Case Definition, and Health Outcomes Following Transrectal Ultrasound-Guided Prostate Needle Biopsy (TRUS-PNB)
    Read more

Specialties & Certification

  • Urologic Oncology

Diseases & Conditions Treated

  • Bladder Cancer
  • Kidney Cancer
  • Penile Cancer
  • Prostate Cancer
  • Testicular Cancer

Treats

  • Adults

Associations/Memberships

  • American Urological Association (AUA)
  • Society of Urologic Oncology
  • Onondaga County Medical Society

Current Hospital Privileges

  • Upstate University Hospital
  • Crouse Hospital
  • VA Medical Center

Languages Spoken (Other Than English)

  • Russian
  • Ukrainian

HealthLink on Air Radio Interview

Web Resources

Publications

Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)

Research Abstract

Clinical Profile Shortcut: http://www.upstate.edu/findadoc/bratslag
Faculty Profile Shortcut: http://www.upstate.edu/faculty/bratslag
Top